Skip to main content
Clinical Trials/NCT06253728
NCT06253728RecruitingNot Applicable

Comprehensive Study of Biochemical Response to Alternative Protein Sources in Different Food Matrices

University of Eastern Finland1 site in 1 country24 target enrollmentStarted: January 18, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
24
Locations
1
Primary Endpoint
Plasma amino acids

Study Overview

Brief Summary

The overall objective of this research is to determine the digestive faith and health impact of protein and fiber rich foods in different food matrices in type 2 diabetes risk population. This is achieved by controlled postprandial intervention where plasma amino acids, lipids, glucose metabolism, bile acids and microbial metabolites are evaluated as well as fecal microbiota and metabolites.

Detailed Description

Detailed research aim of this controlled, randomized crossover postprandial clinical study are:

  1. To study the impact of complex plant- and animal-based foods on glucose metabolism, acute inflammation, and markers of microbial fermentation of fiber and proteins.
  2. To investigate the difference in the gut mediated metabolism induced by naturally occurring fiber fraction bound plant protein or by plant protein with added fiber when compared to animal protein.
  3. To conduct in vitro experiments using fecal samples from participants in the meal study to investigate the distinctions between different animal and plant proteins on both host and microbial metabolites, as well as the function of the gut barrier.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Prevention
Masking
Single (Participant)

Eligibility Criteria

Ages
30 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •30-65 years of age
  • •BMI >25 kg/m2 and <35 kg/m2
  • •Waist circumference with females >85 cm and with males >100 cm

Exclusion Criteria

  • •Certain chronic diseases requiring regular medication (e.g., type 2 diabetes, chronic liver, kidney, thyroid, or gastrointestinal diseases)
  • •Pregnancy or breastfeeding
  • •Gluten-free or vegan diet
  • •Use of antibiotics within the last 12 months
  • •Gastrointestinal surgery within the last two years
  • •High alcohol consumption

Arms & Interventions

Meal 1

Experimental

Meal with plant protein and fiber in an intact structure

Intervention: High fiber and protein meal (Dietary Supplement)

Meal 2

Experimental

Meal with plant protein and fiber, where the cell structure is broken

Intervention: High fiber and protein meal (Dietary Supplement)

Meal 3

Placebo Comparator

Low protein and low fiber cereal

Intervention: Control (Dietary Supplement)

Meal 4

Experimental

High protein and low carbohydrate bread with animal proteins

Intervention: High fiber and protein meal (Dietary Supplement)

Meal 5

Experimental

High protein and low carbohydrate bread with plant protein

Intervention: High fiber and protein meal (Dietary Supplement)

Outcomes

Primary Outcomes

Plasma amino acids

Time Frame: 0-4 hours

Plasma free amino acids were measured at 0, 30, 60, 90, 180, and 240 minutes after consuming the study meal.

Gut derived metabolites

Time Frame: 0-24 hours

Gut derived metabolites are measured with untargeted metabolomics from plasma at 12 hours after consuming the study meal. From fecal sample, the metabolomics are measured at 24 hours after consuming the study meal. Plasma short chain fatty acids are quantified at 12 hours after consuming the study meal.

Secondary Outcomes

  • Plasma glucose(0-4 hours)
  • Inflammation marker(0-4 hours)
  • Plasma triglycerides(0-4 hours)
  • Plasma free fatty acids(0-4 hours)
  • Plasma insulin(0-4 hours)
  • Urine para-cresol(24 hours)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials